The Health Information and Quality Authority (HIQA) has commenced a national public consultation on offering the HPV vaccine to boys.
Currently, the national immunisation programme offers the HPV vaccine to girls in their first year of secondary school. HIQA’s health technology assessment is reviewing the clinical and cost-effectiveness of extending this programme to include vaccinating boys in their first year of secondary school as well.
HIQA’s Director of Health Technology Assessment and Deputy Chief Executive, Dr Máirín Ryan, said: “HPV infection presents a significant and increasing health burden in both males and females, but currently only girls are offered the vaccine. On average, 539 cases of cancer associated with HPV infection are diagnosed every year in Ireland, including cervical, anal, penile and oropharyngeal cancers. HPV infection is also responsible for genital warts, with 90% of these caused by HPV types that are included in the vaccine.”
“No treatment exists for HPV infection, so the focus must be on preventing those at risk from acquiring the virus.”
The draft findings of HIQA’s report have been published for public consultation. The assessment found that vaccinating both boys and girls would have considerable health benefits.
HIQA invites members of the public to give feedback on the draft report until Friday, September 7, 2018.
The completed assessment will be submitted to the Minister for Health and the Health Service Executive as advice and published on the HIQA website.
You can read the draft report and take part in the public consultation on www.hiqa.ie
 has commenced a national public consultation on offering the HPV vaccine to boys.){kind=link}